Paper Details

  1. Home
  2. Paper Details

Ponatinib: An update on its drug targets, therapeutic potential and safety.

Author: DingYue, GaoYue, TaiXin-Ran, WangDong, ZhangChen

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Ponatinib is a third-generation tyrosine kinase inhibitor that targets BCR-ABL and other kinases, making it effective for treating various cancers. However, it has significant cardiovascular toxicity, which limits its clinical use. This review discusses the pharmacokinetics, targets, therapeutic potential, and toxicity of ponatinib and explores ways to mitigate its toxicity.
Paper Details　
Original Abstract of the Article :
Leukemia is a malignancy of the hematopoietic system, and as its pathogenesis has become better understood, three generations of tyrosine kinase inhibitors (TKIs) have been developed. Ponatinib is the third-generation breakpoint cluster region (BCR) and Abelson (ABL) TKI, which has been influential ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.bbcan.2023.188949

データ提供：米国国立医学図書館（NLM）

Ponatinib: A Multifaceted Approach to Cancer Treatment

The battle against cancer is a continuous quest for new weapons and strategies. Imagine cancer as a formidable fortress in a vast, unforgiving desert, requiring a multifaceted approach to conquer. This research focuses on ponatinib, a third-generation tyrosine kinase inhibitor, exploring its potential as a treatment option for various cancers. The researchers sought to understand ponatinib's targets, therapeutic potential, and safety profile.

Ponatinib's Potential: A Multi-Target Approach

The study revealed that ponatinib effectively targets multiple kinases, including BCR-ABL, KIT, RET, and Src, demonstrating its potential as a broad-spectrum treatment for a range of cancers. This is like discovering a new weapon that can attack multiple points of the fortress simultaneously, increasing the chances of success. The researchers found that ponatinib could effectively target several key pathways involved in cancer development, offering hope for a more effective approach to treatment.

Navigating the Challenges of Toxicity

However, the study also highlighted the significant cardiovascular toxicity associated with ponatinib, requiring careful monitoring and management. This is like recognizing the potential dangers of traversing the desert, ensuring safe passage through challenging terrain. The researchers found that while ponatinib holds promise for cancer treatment, its potential side effects require careful consideration and management.

Dr.Camel's Conclusion

This study offers valuable insights into the potential of ponatinib as a multi-target kinase inhibitor for cancer treatment, offering hope for a more effective approach to tackling this formidable disease. It's like discovering a new weapon that can attack multiple points of a fortress simultaneously, increasing the chances of success. However, it's important to recognize the potential side effects of this drug and manage them carefully, ensuring a safe and effective journey through the challenging landscape of cancer treatment.

Date :
  1. Date Completed 2023-09-07
  2. Date Revised 2023-09-22
Further Info :

Pubmed ID

37399979

DOI: Digital Object Identifier

10.1016/j.bbcan.2023.188949

Related Literature

Article Analysis
・Effects of ponatinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.